Variety of NGS Testing Stakeholders Join PrecisionFDA Community at Beta Release | GenomeWeb

NEW YORK (GenomeWeb) – A number of companies and research institutes with an interest in next-generation sequencing-based genetic testing have signed up for PrecisionFDA, an online platform launched today as a beta version by the US Food and Drug Administration that allows the scientific community to test and evaluate NGS assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.